Evidence mapPaperPMID 35964948Full record

ArticleSaudi medical journal2022

Antidiabetic and antioxidant potential of

Ali M Alshabi, Ibrahim A Shaikh

Abstract read
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Xiehuang San Extract Attenuates Insulin Resistance in Obese Rats via Gut Microbiota Modulation: Experimental Evidence.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  3. Article
  4. Unraveling the Antioxidant Activity ofInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ali M AlshabiFrom the Department of Clinical Pharmacy (Alshabi) and from the Department of Pharmacology (Shaikh), College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.
Ibrahim A ShaikhFrom the Department of Clinical Pharmacy (Alshabi) and from the Department of Pharmacology (Shaikh), College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo test the antidiabetic potential of

methodsThe study was carried out in June 2021.

results

conclusion

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2GardeniaInsulinsAnimalsAntioxidantsBlood GlucoseDiet, High-FatHypoglycemic AgentsPlant ExtractsRatsStreptozocinAntioxidantsBlood GlucoseHypoglycemic AgentsInsulinsPlant ExtractsStreptozocinGardenia latifoliahigh fat dietinsulin resistanceSaudi Arabiatype-2 diabetes mellitus

Identifiers

PMID35964948
PMCPMC9749673

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.